1. Home
  2. RLMD vs DWSN Comparison

RLMD vs DWSN Comparison

Compare RLMD & DWSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • DWSN
  • Stock Information
  • Founded
  • RLMD 2004
  • DWSN 1952
  • Country
  • RLMD United States
  • DWSN United States
  • Employees
  • RLMD N/A
  • DWSN N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • DWSN Oil & Gas Production
  • Sector
  • RLMD Health Care
  • DWSN Energy
  • Exchange
  • RLMD Nasdaq
  • DWSN Nasdaq
  • Market Cap
  • RLMD 67.7M
  • DWSN 58.4M
  • IPO Year
  • RLMD N/A
  • DWSN N/A
  • Fundamental
  • Price
  • RLMD $2.09
  • DWSN $2.25
  • Analyst Decision
  • RLMD Hold
  • DWSN
  • Analyst Count
  • RLMD 2
  • DWSN 0
  • Target Price
  • RLMD $1.00
  • DWSN N/A
  • AVG Volume (30 Days)
  • RLMD 335.3K
  • DWSN 74.4K
  • Earning Date
  • RLMD 11-07-2025
  • DWSN 11-11-2025
  • Dividend Yield
  • RLMD N/A
  • DWSN N/A
  • EPS Growth
  • RLMD N/A
  • DWSN N/A
  • EPS
  • RLMD N/A
  • DWSN N/A
  • Revenue
  • RLMD N/A
  • DWSN $55,987,000.00
  • Revenue This Year
  • RLMD N/A
  • DWSN N/A
  • Revenue Next Year
  • RLMD N/A
  • DWSN N/A
  • P/E Ratio
  • RLMD N/A
  • DWSN N/A
  • Revenue Growth
  • RLMD N/A
  • DWSN N/A
  • 52 Week Low
  • RLMD $0.24
  • DWSN $1.08
  • 52 Week High
  • RLMD $3.98
  • DWSN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 55.74
  • DWSN 65.53
  • Support Level
  • RLMD $1.98
  • DWSN $1.76
  • Resistance Level
  • RLMD $2.27
  • DWSN $1.90
  • Average True Range (ATR)
  • RLMD 0.21
  • DWSN 0.17
  • MACD
  • RLMD -0.04
  • DWSN 0.02
  • Stochastic Oscillator
  • RLMD 64.22
  • DWSN 92.04

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About DWSN Dawson Geophysical Company

Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.

Share on Social Networks: